ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,920, issued on March 4, was assigned to Brown University (Providence, R.I.).

"Cyclic peptidomimetic for the treatment of neurological disorders" was invented by John Marshall (Barrington, R.I.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides to compositions and methods useful in the treatment of neurological disorders including, but not limited to, Angelman syndrome, depression, traumatic brain injury, stroke, and Alzheimer's disease. CN2097, a rationally designed cyclic peptidomimetic drug that has been demonstrated to have effectiveness in preclinical models for the treatment of neurological disorders, is rapidly clear...